Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
CANCER DISCOVERY
Journal
Overview
Identity
Other
View All
Overview
publication venue for
Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial
. 11:1688-1699.
2021
Identity
International Standard Serial Number (ISSN)
2159-8274
Electronic International Standard Serial Number (EISSN)
2159-8290
Other
journal abbreviation
CANCER DISCOV